Differences in risk for SARS-CoV-2 infection among healthcare workers.

COVID-19 Healthcare workers SARS-CoV-2

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 27 07 2021
accepted: 08 08 2021
entrez: 30 8 2021
pubmed: 31 8 2021
medline: 31 8 2021
Statut: ppublish

Résumé

Healthcare workers (HCWs) are a risk group for SARS-CoV-2 infection, but which healthcare work that conveys risk and to what extent such risk can be prevented is not clear. Starting on April 24th, 2020, all employees at work (n = 15,300) at the Karolinska University Hospital, Stockholm, Sweden were invited and 92% consented to participate in a SARS-CoV-2 cohort study. Complete SARS-CoV-2 serology was available for n = 12,928 employees and seroprevalences were analyzed by age, sex, profession, patient contact, and hospital department. Relative risks were estimated to examine the association between type of hospital department as a proxy for different working environment exposure and risk for seropositivity, adjusting for age, sex, sampling week, and profession. Wards that were primarily responsible for COVID-19 patients were at increased risk (adjusted OR 1.95 (95% CI 1.65-2.32) with the notable exception of the infectious diseases and intensive care units (adjusted OR 0.86 (95% CI 0.66-1.13)), that were not at increased risk despite being highly exposed. Several units with similar types of work varied greatly in seroprevalences. Among the professions examined, nurse assistants had the highest risk (adjusted OR 1.62 (95% CI 1.38-1.90)). Although healthcare workers, in particular nurse assistants, who attend to COVID-19 patients are a risk group for SARS-CoV-2 infection, several units caring for COVID-19 patients had no excess risk. Large variations in seroprevalences among similar units suggest that healthcare work-related risk of SARS-CoV-2 infection may be preventable.

Identifiants

pubmed: 34458081
doi: 10.1016/j.pmedr.2021.101518
pii: S2211-3355(21)00208-4
pmc: PMC8379088
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101518

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Nat Commun. 2020 Jul 8;11(1):3500
pubmed: 32641730
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Emerg Infect Dis. 2020 Oct;26(10):2416-2419
pubmed: 32614768
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Infect Ecol Epidemiol. 2020 Aug 5;10(1):1789036
pubmed: 32939231
Lancet Infect Dis. 2020 Nov;20(11):1263-1271
pubmed: 32679081
Clin Infect Dis. 2020 Oct 03;:
pubmed: 33011792
BMJ. 2020 Oct 28;371:m3582
pubmed: 33115726
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Cell. 2020 Apr 16;181(2):223-227
pubmed: 32220310
Lancet. 2020 May 23;395(10237):1602
pubmed: 32446403
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
Scand J Public Health. 2021 Jun 19;:14034948211022434
pubmed: 34148454
JAMA. 2020 Sep 1;324(9):893-895
pubmed: 32780804
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Autoimmunity. 2019 Feb;52(1):1-11
pubmed: 30835561

Auteurs

K Miriam Elfström (KM)

Karolinska University Hospital, Stockholm SE-141 86, Sweden.

Jonas Blomqvist (J)

Karolinska University Hospital, Stockholm SE-141 86, Sweden.

Peter Nilsson (P)

Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.

Sophia Hober (S)

Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.

Elisa Pin (E)

Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.

Anna Månberg (A)

Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.

Ville N Pimenoff (VN)

Karolinska Institute, Stockholm, Sweden.
University of Oulu, Oulu, Finland.

Laila Sara Arroyo Mühr (LS)

Karolinska Institute, Stockholm, Sweden.

Kalle Conneryd Lundgren (KC)

Karolinska University Hospital, Stockholm SE-141 86, Sweden.

Joakim Dillner (J)

Karolinska University Hospital, Stockholm SE-141 86, Sweden.
Karolinska Institute, Stockholm, Sweden.

Classifications MeSH